Further characterization of reproductive abnormalities in mCd59b knockout mice: A potential new function of mCd59 in male reproduction

Journal of Immunology

Volumn 175, Issue 10, 2005, Pages 6294-6302

  Qin, Xuebin ^a,b   Dobarro, Martin ^a   Bedford, Sylvia J ^c   Ferris, Sean ^b   Miranda, Patricia V ^c   Song, Wenping ^b   Bronson, Roderick T ^b   Visconti, Pablo E ^c   Halperin, Jose A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; FOLLITROPIN; LUTEINIZING HORMONE; MEMBRANE PROTEIN; TESTOSTERONE;

ACROSOME REACTION; APOPTOSIS; ARTICLE; CD59 GENE; CELL VIABILITY; COMPLEMENT ACTIVATION; EFFECTOR CELL; ENZYME ACTIVATION; GENE; GENE DELETION; GENE TARGETING; HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MALE FERTILITY; MULTINUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN PHOSPHORYLATION; REPRODUCTION; SEMINIFEROUS TUBULE; SPERMATOGENESIS; SPERMATOZOON CAPACITATION;

EID: 27744552983     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.10.6294     Document Type: Article

References (53)

1. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
2. Luzzatto, L., and M. Bessler. 1996. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Curr. Opin. Hematol. 3: 101-110.
3. Walsh, P. C. 2002. Campbell's Urology, 8th Ed. Saunders, Philadelphia.
4. Holmes, C. H., K. L. Simpson, H. Okada, N. Okada, S. D. Wainwright, D. F. Purcell, and J. M. Houlihan. 1992. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur. J. Immunol. 22: 1579-1585.
5. Simpson, K. L., and C. H. Holmes. 1994. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis. Immunology 81: 452-461.
6. Morgan, B. P., and C. L. Harris. 1999. Complement Regulatory Proteins. Academic Press, London.
7. Qin, X., N. Krumrei, L. Grubissich, M. Dobarro, H. Aktas, G. Perez, and J. A. Halperin. 2003. Deficiency of the mouse complement regulatory protein mCd59b results in spontaneous hemolytic anemia with platelet activation and progressive male infertility. Immunity 18: 217-227.
8. Xu, C., D. Mao, V. M. Holers, B. Palanca, A. M. Cheng, and H. Molina. 2000. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287: 498-501.
9. Mao, D., X. Wu, C. Deppong, L. D. Friend, G. Dolecki, D. M. Nelson, and H. Molina. 2003. Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 19: 813-822.
10. Holers, V. M., G. Girardi, L. Mo, J. M. Guthridge, H. Molina, S. S. Pierangeli, R. Espinola, L. E. Xiaowei, D. Mao, C. G. Vialpando, and J. E. Salmon. 2002. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195: 211-220.
11. Perricone, R., N. Pasetto, C. De Carolis, E. Vaquera, E. Piccione, L. Baschieri, and L. Fontana. 1992. Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma. Clin. Exp. Immunol. 89: 154-157.
12. D'Cruz, O. J., G. G. Haas, Jr., and H. Lambert. 1990. Evaluation of antisperm complement-dependent immune mediators in human ovarian follicular fluid. J. Immunol. 144: 3841-3848.
13. Rooney, I. A., J. P. Atkinson, E. S. Kral, G. Schonfeld, K. Polakoski, J. E. Saffitz, and B. P. Morgan. 1993. Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis. J. Exp. Med. 177: 1409-1420.
14. Rooney, I. A., A. Davies, and B. P. Morgan. 1992. Membrane attack complex (MAC)-mediated damage to spermatozoa: protection of the cells by the presence on their membranes of MAC inhibitory proteins. Immunology 75: 499-506.
15. Powell, M. B., K. J. Marchbank, N. K. Rushmere, C. W. van den Berg, and B. P. Morgan. 1997. Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59. J. Immunol. 158: 1692-1702.
16. Qian, Y. M., X. Qin, T. Miwa, X. Sun, J. A. Halperin, and W. C. Song. 2000. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59. J. Immunol. 165: 2528-2534.
17. Qin, X., T. Miwa, H. Aktas, M. Gao, C. Lee, Y. M. Qian, C. C. Morton, A. Shahsafaei, W. C. Song, and J. A. Halperin. 2001. Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b. Mamm. Genome 12: 582-589.
18. Harris, C. L., S. M. Hanna, M. Mizuno, D. S. Holt, K. J. Marchbank, and B. P. Morgan. 2003. Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison. Immunology 109: 117-126.
19. Wessels, M. R., P. Butko, M. Ma, H. B. Warren, A. L. Lage, and M. C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92: 11490-11494.
20. Chappell, P. E., J. P. Lydon, O. M. Conneely, B. W. O'Malley, and J. E. Levine. 1997. Endocrine defects in mice carrying a null mutation for the progesterone receptor gene. Endocrinology 138: 4147-4152.
21. Maione, B., M. Lavitrano, C. Spadafora, and A. A. Kiessling. 1998. Sperm-mediated gene transfer in mice. Mol. Reprod. Dev. 50: 406-409.
22. Pickering, M. C., H. T. Cook, J. Warren, A. E. Bygrave, J. Moss, M. J. Walport, and M. Botto. 2002. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 31: 424-428.
23. Rosoklija, G. B., A. J. Dwork, D. S. Younger, G. Karlikaya, N. Latov, and A. P. Hays. 2000. Local activation of the complement system in endoneurial microvessels of diabetic neuropathy. Acta Neuropathol 99: 55-62.
24. Jeyaraj, D. A., G. Grossman, and P. Petrusz. 2003. Dynamics of testicular germ cell apoptosis in normal mice and transgenic mice overexpressing rat androgen-binding protein. Reprod. Biol. Endocrinol. 1: 48.
25. Matsuki, S., Y. Iuchi, Y. Ikeda, I. Sasagawa, Y. Tomita, and J. Fujii. 2003. Suppression of cytochrome c release and apoptosis in testes with heat stress by minocycline. Biochem. Biophys. Res. Commun. 312: 843-849.
26. Krzanowska, H. 1974. The passage of abnormal spermatozoa through the utero-tubal junction of the mouse. J. Reprod. Fertil. 38: 81-90.
27. Krzanowska, H. 1981. Sperm head abnormalities in relation to the age and strain of mice. J. Reprod. Fertil. 62: 385-392.
28. Nayernia, K., I. M. Adham, E. Burkhardt-Gottges, J. Neesen, M. Rieche, S. Wolf, U. Sancken, K. Kleene, and W. Engel. 2002. Asthenozpospermia in mice with targeted deletion of the sperm mitochondrion-associated cysteine-rich protein (Smcp) gene. Mol. Cell Biol. 22: 3046-3052.
29. Visconti, P. E., J. L. Bailey, G. D. Moore, D. Pan, P. Olds-Clarke, and G. S. Kopf. 1995. Capacitation of mouse spermatozoa. I. Correlation between the capacitation state and protein tyrosine phosphorylation. Development 121: 1129-1137.
30. Visconti, P. E, G. D. Moore, J. L. Bailey, P. Leclerc, S. A. Connors, D. Pan, P. Olds-Clarke, and G. S. Kopf. 1995. Capacitation of mouse spermatozoa. II. Protein tyrosine phosphorylation and Capacitation are regulated by a cAMP-dependent pathway. Development 121: 1139-1150.
31. Moore, G. D., T. Ayabe, P. E. Visconti, R. M. Schultz, and G. S. Kopf. 1994. Roles of heterotrimeric and monomeric G proteins in sperm-induced activation of mouse eggs. Development 120: 3313-3323.
32. Tao, J., E. S. Critser, and J. K. Critser. 1993. Evaluation of mouse sperm acrosomal status and viability by flow cytometry. Mol. Reprod. Dev. 36: 183-194.
33. Holt, D. S., M. Botto, A. E. Bygrave, S. M. Hanna, M. J. Walport, and B. P. Morgan. 2001. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 98: 442-449.
34. Visconti, P. E., and G. S. Kopf. 1998. Regulation of protein phosphorylation during sperm capacitation. Biol. Reprod. 59: 1-6.
35. Murray, E. W., and S. M. Robbins. 1998. Antibody cross-linking of the glycosylphosphatidylinositol-linked protein CD59 on hematopoietic cells induces signaling pathways resembling activation by complement. J. Biol. Chem. 273: 25279-25284.
36. Stefanova, I., V. Horejsi, I. J. Ansotegui, W. Knapp, and H. Stockinger. 1991. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254: 1016-1019.
37. Wang, W., L. H. Shang, and D. O. Jacobs. 2002. Complement regulatory protein CD59 involves c-SRC related tyrosine phosphorylation of the creatine transporter in skeletal muscle during sepsis. Surgery 132: 334-340.
38. Mastellos, D., and J. D. Lambris. 2002. Complement: more than a "guard" against invading pathogens? Trends Immunol. 23: 485-491.
39. Holmes, E., F. W. Bonner, B. C. Sweatman, J. C. Lindon, C. R. Beddell, E. Rahr, and J. K. Nicholson. 1992. Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine. Mol. Pharmacol. 42: 922-930.
40. Sun, X., C. D. Funk, C. Deng, A. Sahu, J. D. Lambris, and W. C. Song. 1999. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc. Natl. Acad. Sci. USA 96: 628-633.
41. Zheng, X., T. L. Saunders, S. A. Camper, L. C. Samuelson, and D. Ginsburg. 1995. Vitronectin is not essential for normal mammalian development and fertility. Proc. Natl. Acad. Sci. USA 92: 12426-12430.
42. Riley, R. C., P. L. Tannenbaum, D. H. Abbott, and J. P. Atkinson. 2002. Cutting edge: inhibiting measles virus infection but promoting reproduction: an explanation for splicing and tissue-specific expression of CD46. J. Immunol. 169: 5405-5409.
43. Inoue, N., M. Ikawa, T. Nakanishi, M. Matsumoto, M. Nomura, T. Seya, and M. Okabe. 2003. Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm. Mol. Cell Biol. 23: 2614-2622.
44. Miwa, T., L. Zhou, B. Hilliard, H. Molina, and W. C. Song. 2002. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99: 3707-3716.
45. De Waal, R. M., G. Schrijver, M. J. Bogman, K. J. Assmann, and R. A. Koene. 1988. An improved sensitive and simple microassay of mouse complement. J. Immunol. Methods 108: 213-221.
46. Pratt, J. R., S. A. Basheer, and S. H. Sacks. 2002. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 8: 582-587.
47. Cianflone, K., Z. Xia, and L. Y. Chen. 2003. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim. Biophys. Acta 1609: 127-143.
48. D'Cruz, O. J., and G. G. Haas, Jr. 1993. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury. Fertil. Steril. 59: 876-884.
49. Jiang, H., and S. Pillai. 1998. Complement regulatory proteins on the sperm surface: relevance to sperm motility. Am. J. Reprod. Immunol. 39: 243-248.
50. Kondoh, G., H. Tojo, Y. Nakatani, N. Komazawa, C. Murata, K. Yamagata, Y. Maeda, T. Kinoshita, M. Okabe, R. Taguchi, and J. Takeda. 2005. Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization. Nat. Med. 11: 160-166.
51. Cross, N. L. 2004. Reorganization of lipid rafts during capacitation of human sperm. Biol. Reprod. 71: 1367-1373.
52. Kazazian, H. H., Jr. 2004. Mobile elements: drivers of genome evolution. Science 303: 1626-1632.
53. Kazazian, H. H., Jr., and J. V. Moran. 1998. The impact of L1 retrotransposons on the human genome. Nat. Genet. 19: 19-24.